Scientific Program

Scientific Program

Thursday, May 23, 2013

14.00 – 14.05	Welcome Address: Helmut Kettenmann
14.05 - 15.20	Session I Chair: Manfred Westphal
14.05 – 14.45	Plenary I Peter Canoll Pathology & Cell Biology, College of Physicians and Surgeons, Columbia University, New York, USA Tracking gliomagenesis: From glial progenitor to proneural glioma
14.45 – 15.05	Oral Presentation I Joerg Bartsch Neurosurgery, Philipps-University Marburg, Marburg, Germany A critical role for the metalloprotease-disintegrin adam8 in glioma growth
15.05 - 15.25	Oral Presentations II Axel Pagenstecher Neuropathology, University of Marburg, Marburg, Germany The assay medium is the message: in cns tissue the gpi-anchored mmp17 and mmp25 are the most potent mt-mmp-mediators of the astrocyte
15.25 – 16.00	Poster Session and Coffee Break
16.00 – 17.20	Session II Chair: Darko Markovic
16.00 – 16.40	Plenary II Michael Weller Klinik für Neurologie, UniversitätsSpital Zürich Personalized medicine for glioblastoma: facts and fictions
16.40 - 17.00	Oral Presentation III Paolo Malatesta DIMES, University of Genova, Italy Targeting malignant gliomas with engineered herpes virus
17.00 – 17.20	Oral Presentation IV Stefanie Robel Neurobiology, University of Alabama at Birmingham (UAB), USA The role of reactive astrocytes in glioma associated epilepsy
17.20 – 17.50	Coffee Break and Poster Session
17.50 – 19.10	Session III Chair: Christel Herold-Mende
17.50 – 18.30	Plenary III Ruggero De Maria Istituto Regina Elena, Rome, Italy Targeting cancer stem cells in glioblastoma
18.30 – 18.50	Oral Presentation V Johannes vom Berg Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland Local interleukin-12 in combination with systemic checkpoint blockade leads to t-cell dependent rejection of advanced stage glioma
18.50 – 19.10	Oral Presentation VI Rolf Mentlein Anatomy, University of Kiel, Germany Functional role of transmembrane chemokines in gliomas
19.20 – 20.00	Bus Transfer to Berlin Museum of Medical History / Charité
20.00	Reception in the Berlin Museum of Medical History / Charité

Friday, May 24, 2013

9.00 - 10.00	Session IV Chair: Rainer Glass
9.00 - 9.40	Plenary IV Gabriele Bergers University of California, Departments of Neurological Surgery and Anatomy, San Francisco, USA VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
9.40 - 10.10	Oral Presentation VII Roland Kälin Department of Neuropathology, Charité – Universitätsmedizin Berlin, Germany Dissecting the role of apelin signaling in gliomagenesis
10.10 – 10.40	Poster Session and Coffee Break
10.40 – 11.40	Session V Chair: Jürgen Kiwit
10.40 – 11.20	Plenary V Bozena Kaminska Nencki Institute of Experimental Biology, Department of Cell Biology, Warsaw, Poland Molecular mechanisms driving pro-tumorigenic polarization of microglia in gliomas
11.20 – 11.40	Oral Presentation VIII Dolores Hambardzumyan, Neurosciences, Cleveland Clinic, Cleveland, USA Somatic cell-specific gene transfer models of brain tumors to study the distinct roles of resident microglia and infiltrating monocytes in glioblastoma
11.40 – 12.30	Lunch
12.30 – 15.50	Session VI Chair: Frank Heppner
12.30 – 13.10	Plenary VI Peter Vajkoczy Klinik und Poliklinik für Neurochirurgie, Charité - Campus Virchow-Klinikum, Berlin Microglia home to the perivascular niche and contribute to angiogenesis in brain tumors
13.10 – 13.50	Plenary VII Michael Platten Neurologische Klinik, Neuroonkologie, Universtätsklinikum Heidelberg The immunosuppressive microenvironment in gliom
13.50 – 14.10	Coffee Break
14.10 – 14.50	Plenary VIII Hui Zong Department of Microbiology, Immunology, and Cancer Biology, Center for Cell Signaling, University of Virginia School of Medicine, Charlottesville, VA 22908-0577, USA Understanding tumor cell maneuvers in brain tumors with MADM, a genetic mosaic system
15.00	Departure

Sponsors